NCT03060811

Brief Summary

Trimethylamine N-oxide (TMAO) is a small organic compound naturally present in fish and seefood or generated by the bacterial breakdown of dietary phosphatidylcholine and carnitine-containing foods within the human gut microbiome. Elevated serum TMAO was previously reported to be associated with an elevated risk for cardiovascular events. Aim of this study was to investigate the association between plasma levels of TMAO with the Mediterranean diet in a cohort of healthy adults.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2016

Shorter than P25 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 22, 2016

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 22, 2016

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2017

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

February 14, 2017

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 23, 2017

Completed
Last Updated

February 27, 2017

Status Verified

February 1, 2017

Enrollment Period

3 months

First QC Date

February 14, 2017

Last Update Submit

February 24, 2017

Conditions

Outcome Measures

Primary Outcomes (2)

  • Adherence to Mediterranean Diet by Predimed Questionnaire

    Validated 14-item tool of adherence to the Mediterranean diet, with three categories of adherence (≤5, low adherence, 6-9, average adherence and ≥10 points, high adherence)

    September 2016 to December 2016

  • Trimethylamine N-oxide plasma levels

    ultra high-performance liquid chromatography

    September 2016 to December 2016

Secondary Outcomes (1)

  • cardiovascular risk

    September 2016 to December 2016

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Healthy subjects (n=84) aged 21-50 years with a BMI of 20-29.9 kg/m2, chosen among hospital volunteers and employees from the same geographical area. A sample size of n=40 was determined from a power analysis of a within-subject design to detect a 10% difference of plasma TMAO concentration at alfa\<0.05 and β =0.8. Participants were screened by the use of a blood chemistry profile, cell count, and health history questionnaire.

You may qualify if:

  • healthy subjects of both gender

You may not qualify if:

  • age\>65 years
  • \> BMI 30 kg/m2
  • vegetarians
  • smokers
  • gastrointestinal diseases or complaints
  • chronic illnesses or other metabolic diseases (including trimethylaminuria)
  • abnormal blood chemistry values indicative of organ dysfunctions
  • nutritional supplements, antibiotics or probiotics within 2 months of recruitment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Researcher/Adjunct Professor

Study Record Dates

First Submitted

February 14, 2017

First Posted

February 23, 2017

Study Start

September 22, 2016

Primary Completion

December 22, 2016

Study Completion

February 1, 2017

Last Updated

February 27, 2017

Record last verified: 2017-02

Data Sharing

IPD Sharing
Will not share